Individual Patient Data Meta-analyses in Cancer
Author Information
Author(s): M Clarke, L Stewart, J-P Pignon, L Bijnens
Primary Institution: ICRF Clinical Trial Service Unit, Radcliffe Infirmary, Oxford, UK
Hypothesis
The paper illustrates the importance of individual patient data meta-analyses in cancer research.
Conclusion
Individual patient data meta-analyses can provide more reliable assessments of cancer treatments and help avoid unnecessary treatments.
Supporting Evidence
- Meta-analyses can reveal small but significant differences in treatment effects.
- Individual patient data allows for more accurate subgroup analyses.
- Long-term follow-up can uncover unexpected treatment benefits.
Takeaway
This study shows that looking at data from many cancer trials together can help us understand which treatments work best.
Methodology
The study involved systematic reviews and meta-analyses of individual patient data from randomized controlled trials.
Potential Biases
There may be risks of bias due to the reliance on data from individual trials, which can vary in quality.
Limitations
The paper does not address the potential biases in the individual trials included in the meta-analyses.
Participant Demographics
The study references data from over 40,000 women in trials for breast cancer.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website